Prostate Cancer Diagnostics Market Estimated to Grow with a Healthy CAGR During Forecast Period 2022-2030
Prostate Cancer Diagnostics Market Overview
The global Prostate Cancer Diagnostics Market is
growing continually at a rapid pace, mainly due to the increasing prevalence of
the condition. Besides, serious risk factors of prostate cancer, including
race, age, and genetics, alongside, the changing & sedentary lifestyle and
growing obesity disorders are driving the growth of the market, leading to the
occurrence of this type of cancer.
Also, the emergence of novel medicines &
therapies is accelerating market growth, giving the best outcomes. According to
Market Research Future (MRFR), the Prostate Cancer Diagnostics Market is expected to garner exponential accruals by
2030. In its recently published analysis, MRFR also asserts that the market
would register an impressive CAGR of 7.50% throughout the forecast period (2022
– 2030).
The rise in the funding support from the public and
private sector in the field of drug development are fostering market growth.
The demand for sophisticated devices is, in turn, contributing to the growth of
the market to a great extent.
Conversely, low awareness among people about the
availability and the benefits of prostate cancer treatment and loss of patent
protection for drugs impede market growth. Also, the high production cost of
the devices & medicines required for the management of the disease
alongside, the skepticism of physicians towards the advancement &
efficacies of the treatments is estimated to obstruct the growth of the global
prostate cancer market. Similarly,
the high cost associated with the treatment of prostate cancer and side-effects
of surgeries such as urinary incontinence and impotence along with the surgical
risks like heart attack, stroke, and blood clots are restricting the growth of
the market. Nevertheless, seminal efforts & investments by the key market
players would support the market growth, bringing about innovative drugs &
therapies for the treatments.
Prostate Cancer Diagnostics Market Segmentation
The report is segmented into three market dynamics to widen
the scope of understanding,
By Product Type : Targeted Therapies, Hormone
Therapy, and Therapeutic Vaccines, among others.
By End-user :
Clinics and Hospitals, among others.
Prostate Cancer Diagnostics Market Regional Analysis
North America leads the global prostate cancer market with
the largest share. Factors such as the rising prevalence of cancer, increasing
numbers of geriatric population, alongside the increasing R&D activities to
discover breakthrough therapies and medicines drive the regional market growth.
Besides, the presence of well-developed economies, many large players, and
proliferating healthcare sector, predominantly foster the market growth in the
region. In Sync with the same growth trends, the prostate cancer market in
North America is likely to maintain its market position in the coming years.
Europe takes the second leading position in the global
prostate cancer market, heading with the well-proliferated healthcare sectors
and the resurging economy in the region. Moreover, the rising prevalence of the
prostate cancer alongside, the strong growth in Germany and France markets
drive the regional market growth at a large scale. The availability of
innovative & advanced treatment facilities, and rising skilled medical
professionals, commutatively act as a major tailwind impacting the regional
market growth. With the rising numbers of aging populaces, the European
prostate cancer market is estimated to register a phenomenal CAGR throughout
the forecast period.
The prostate cancer market in the Asia Pacific region is
emerging as a lucrative market globally. Factors such as the spreading
awareness about the healthcare and availability of new treatment methods act as
significant growth propellers. Also, increasing demand for the latest treatment
methods and the rapidly developing healthcare technology influences the market
growth in the region.
Prostate Cancer Diagnostics Market Major Players
Prostate
Cancer Diagnostics Market Players include Bayer Pharma AG (Berlin),
OncoGenex Pharmaceuticals Inc. (US), Progenics Pharmaceuticals, Inc. (US),
OncBioMune Pharmaceuticals Inc. (US), TOLMAR Inc. (US), Endo Pharmaceuticals
Inc., and Tokai Pharmaceuticals, Inc., among others.
At
Market Research Future (MRFR), we enable our customers to unravel the
complexity of various industries through our Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme
objective to provide the optimum quality market research and intelligence
services to our clients.
Contact us:
Market
Research Future (part of Wantstats Research and Media Private Limited),
99
Hudson Street, 5Th Floor,
New
York, New York 10013
United
States of America
+1
628 258 0071
Email:
sales@marketresearchfuture.com
.jpg)
Comments
Post a Comment